- Report
- January 2025
- 144 Pages
Global
From €2709EUR$2,900USD£2,292GBP
- Report
- October 2024
- 186 Pages
Global
From €3312EUR$3,545USD£2,802GBP
€3680EUR$3,939USD£3,113GBP
- Report
- March 2022
- 120 Pages
Global
From €2336EUR$2,500USD£1,976GBP
- Report
- March 2018
- 120 Pages
Global
From €3970EUR$4,250USD£3,359GBP
- Report
- March 2025
- 91 Pages
Global
From €3500EUR$4,013USD£3,065GBP
Natamycin is an antifungal drug used to treat a variety of fungal infections. It is used to treat superficial fungal infections of the eye, ear, and skin, as well as systemic fungal infections. Natamycin is also used to treat infections caused by certain bacteria, such as those that cause meningitis. It is commonly used in the treatment of infectious diseases, including those caused by fungi, bacteria, and viruses.
Natamycin is a polyene macrolide antibiotic, which is produced by the fermentation of Streptomyces natalensis. It is available in the form of eye drops, ointments, and creams, as well as oral tablets and capsules. Natamycin is generally well tolerated and has few side effects.
The Natamycin market is an important part of the Infectious Diseases Drugs market. It is used to treat a variety of fungal infections, and is an important part of the treatment of infectious diseases. Natamycin is a safe and effective drug, and is widely used in the treatment of infectious diseases.
Some companies in the Natamycin market include Allergan, Merck, Pfizer, and Novartis. Show Less Read more